Cell Tissue Res
J Am Coll Cardiol 2023;81:1902-14.ArticlePubMed 113
The associated weight loss benefits attracted attention and between 2021 -2024 when weight-loss approvals were obtained, media coverage dramatically increased demand
Patients should not interpret GLP-1 therapy as a replacement for levothyroxine or as a treatment for the underlying autoimmune process
John-Michael Gamble, PhD, Clinical Associate Professor at the University of Waterloo, Canada, discussed the origin and biological plausibility of the concern over suicide risk in people using GLP-1 receptor agonists, relevant scientific evidence and its limitations, and the implications for prescribers and their patients
Carla Prado, a nutrition researcher in the Faculty of Agricultural, Life & Environmental Sciences and lead author on the commentary, explains this rate of muscle decline is significantly higher than what is typically observed with calorie-reduced diets or normal aging and could lead to a host of long-term health issues - including decreased immunity, increased risk of infections and poor wound healing